JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaetgens, R. L.
Right arrow Articles by Zamponi, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaetgens, R. L.
Right arrow Articles by Zamponi, G. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 32, 22428-22436, August 6, 1999


Multiple Structural Domains Contribute to Voltage-dependent Inactivation of Rat Brain alpha 1E Calcium Channels*

Renée L. SpaetgensDagger and Gerald W. Zamponi§

From the Department of Pharmacology and Therapeutics, Neuroscience Research Group, University of Calgary, Calgary, Alberta T2N 4N1, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have investigated the molecular determinants that mediate the differences in voltage-dependent inactivation properties between rapidly inactivating (R-type) alpha 1E and noninactivating (L-type) alpha 1C calcium channels. When coexpressed in human embryonic kidney cells with ancillary beta 1b and alpha 2-delta subunits, the wild type channels exhibit dramatically different inactivation properties; the half-inactivation potential of alpha 1E is 45 mV more negative than that observed with alpha 1C, and during a 150-ms test depolarization, alpha 1E undergoes 65% inactivation compared with only about 15% for alpha 1C. To define the structural determinants that govern these intrinsic differences, we have created a series of chimeric calcium channel alpha 1 subunits that combine the major structural domains of the two wild type channels, and we investigated their voltage-dependent inactivation properties. Each of the four transmembrane domains significantly affected the half-inactivation potential, with domains II and III being most critical. In particular, substitution of alpha 1C sequence in domains II or III with that of alpha 1E resulted in 25-mV negative shifts in half-inactivation potential. Similarly, the differences in inactivation rate were predominantly governed by transmembrane domains II and III and to some extent by domain IV. Thus, voltage-dependent inactivation of alpha 1E channels is a complex process that involves multiple structural domains and possibly a global conformational change in the channel protein.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The influx of calcium through neuronal voltage-gated calcium channels regulates a wide range of cellular processes, including neurotransmitter release, activation of Ca2+-dependent enzymes and second messenger cascades, gene regulation, and proliferation. To date, the primary structures of at least nine different neuronal Ca2+ channel alpha 1 subunits have been identified. alpha 1C, alpha 1D, and alpha 1F encode L-type channels (1-3); alpha 1B defines N-type channels (4-6); alpha 1A encodes both P- and Q-type channels (7-11); alpha 1G, alpha 1H, and alpha 1I form T-type channels (12, 13); and alpha 1E probably encodes a component of the "resistant" current identified in several neuronal preparations (14-16).

A key mechanism by which these channels achieve the tight regulation of internal calcium levels is a fast, voltage-dependent inactivation process. Calcium channel inactivation is a critical determinant of the temporal precision of calcium signals and serves to prevent long term increases in intracellular calcium levels, which are cytotoxic to neurons (17-19). The inactivation of calcium channels at presynaptic terminals may also contribute to short term synaptic plasticity (20). Additionally, cumulative inactivation of neuronal calcium channels during a train of action potentials can lead to variable depression of calcium entry depending on the subunit composition of calcium channels present (21). Unlike the well characterized "ball and chain" (22-24) and "hinged lid" (25-28) inactivation mechanisms of voltage-dependent potassium and sodium channels, the molecular mechanisms for voltage-dependent inactivation in calcium channel proteins are incompletely understood. A study by Zhang et al. (29) has revealed that the domain I S6 region is a critical determinant of the differences in voltage-dependent inactivation properties observed with marine ray (doe-I) alpha 1E and rabbit brain alpha 1A calcium channels. More recently, several individual amino acid substitutions throughout the calcium channel alpha 1 subunit, including the domain I-II linker region, the proximal carboxyl-terminal region, and the S6 regions in domains III and IV (7, 11, 30-36) have been shown to reduce or abolish voltage-dependent inactivation. These observations suggest that voltage-dependent inactivation of calcium channels may perhaps involve multiple structural elements.

In order to more systematically examine the molecular determinants governing calcium channel inactivation, we have created a series of chimerical calcium channel alpha 1 subunits, which combine the structural features of rapidly inactivating alpha 1E and noninactivating alpha 1C calcium channels, expressed them transiently in HEK cells, and assessed their inactivation properties via patch clamp. Our data indicate that each transmembrane domain contributes, to varying degrees, to voltage-dependent inactivation of rat brain alpha 1E calcium channels and that inactivation probably involves a complex global conformational change throughout the channel protein. We hypothesize that the molecular mechanisms underlying fast voltage-dependent inactivation in neuronal calcium channels may be analogous to the slower C-type inactivation process common to many types of potassium channels (23, 37, 38).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials

cDNAs coding for wild type rat brain alpha 1E (rbE-II; GenBankTM accession no. L15453), alpha 1C (rbC-II; GenBankTM accession no. M67515), and alpha 2-delta subunits were kindly donated by Dr. T. P. Snutch. The beta 1b subunit was provided by Dr. Perez-Reyes. The pEGFP-C1 was donated by Dr. Robert Dunn. Unless stated otherwise, chemical reagents were purchased from Sigma. Restriction enzymes were obtained from Life Technologies, Inc. and from New England Biolabs.

Site-directed Mutagenesis

Unique restriction enzyme sites were inserted into the alpha 1C and alpha 1E cDNA constructs via site-directed mutagenesis at exactly complementary positions at the beginning of the domain I-II (AvrII) and the domain II-III (SalI) linker regions and about 20 amino acid residues into the domain III-IV linker region (MluI) as outlined below.

Site-directed Mutagenesis of alpha 1C-- The rbC-II construct in Bluescript(KS-) was first cut with SalI, blunted and then religated in order to eliminate two undesired SalI sites in the polylinker and the 5'-untranslated region. Subsequently, the construct was cut with NheI and recircularized to temporarily eliminate 2.5 kilobase pairs of coding region at the 3'-end. This construct was used as the template for all subsequent rounds of mutagenesis. Using the QuikChange site-directed mutagenesis kit (Stratagene), the following mutations were created: silent mutation at bp1 1199 to create an AvrII site; silent mutation at bp 2256 to generate a SalI site; and silent mutation at bp 2804 to eliminate an undesired endogenous AvrII site. In order to create chimeras that involved domain switches at the junction between domains III and IV, it was necessary to engineer an MluI site into the cDNA sequence. In rbC-II, this required a nonsilent mutation at bp 3606 to the corresponding amino acid residue found in alpha 1E (arginine to threonine substitution). Thus, a fourth round of mutagenesis to create the MluI site was carried out; however, this particular construct was used only for chimeras involving transitions between domains III and IV. Because the amino acid was switched to the complementary alpha 1E residue, the mutation became silent once the domain IV switch had occurred. For all other chimeras, the construct lacking the MluI site was used as the parent channel source. The successful addition/deletion of restriction sites was first confirmed via restriction digests, and the complete coding region was sequenced to confirm the absence of errors. For both constructs, the excised 2.5-kilobase pair NheI fragment was reintroduced to yield two full-length clones in Bluescript containing the unique restriction sites (CCCC, CCCC(+MluI)). CCCC was subcloned into PMT2 (XS) using the KpnI and NotI sites flanking the 5'- and 3'-ends of the clone, respectively.

Site-directed Mutagenesis of alpha 1E-- Prior to mutagenesis, rbE-II in Bluescript(SK-) was cut with NotI and recircularized to eliminate a 200-bp fragment in the 5'-untranslated region, thus leaving a single NotI site at the 5'-end. The construct was then cut with XhoI and recircularized to temporarily reduce its size by 1.7 kilobase pairs at the 3'-end. This construct was used as the template for all subsequent rounds of mutagenesis. Using the QuikChange kit, the following silent mutations were created: the addition of an AvrII site at bp 890; the addition of a SalI site at bp 1959; and the addition of an MluI site at bp 4224. Because the NotI and KpnI flanking sites in rbE-II were in opposite orientation compared with those flanking the rbC-II insert, it was necessary to replace the NotI and KpnI sites flanking rbE-II with KpnI and NotI, respectively, again using the QuikChange kit. The successful completion of the five rounds of mutagenesis was confirmed via restriction digests, and the excised 1.7-kilobase pair XhoI fragment was reintroduced to yield the full-length clone EEEE. This construct was completely sequenced from the 5'-end to the first XhoI (bp 5044) site to ensure that no PCR errors had occurred. The insert was then subcloned into PMT2 (XS) using KpnI and NotI.

Creation of alpha 1E/alpha 1C Chimeras

CCCE/EEEC-- These chimeras were assembled in Bluescript using CCCC (+MluI) and EEEE by switching the MluI-NotI fragments among the two parent channels. Both chimeras were subsequently subcloned into pMT2 (XS) using KpnI and NotI. Again, note that in these two chimeras the nonsilent Mlu I mutation in CCCC (+MluI) becomes silent.

CCEC-- CCEC was created by replacement of a SalI fragment between the II-III linker and the 3' pMT2 polylinker of CCCC with the corresponding fragment of EEEC in pMT2.

EECE-- EECE was created by replacement of a SalI fragment from EEEE (II-III linker, 3' pMT2 polylinker) with the corresponding fragment from CCCE in pMT2.

CEEC-- CEEC was created by replacement of an AvrII fragment between the 5' pMT2 sequence (900 bp 5' to the pMT2 polylinker) and the I-II linker region of EEEC with the corresponding fragment of CCCC in pMT2.

ECCE-- ECCE was created by replacement of an AvrII fragment from CCCE (900 bp 5' to the pMT2 polylinker, I-II linker) with the corresponding fragment from EEEE.

CEEE/ECCC-- Domains I of EEEE and CCCC were swapped via excision of the AvrII (pMT2, I-II linker) fragments.

EECC/CCEE-- Domains III and IV of EEEE and CCCC were swapped via excision of the SalI (II-III linker, 3' pMT2 polylinker) fragments.

ECEE-- Domains III and IV of ECCC were replaced via excision of the SalI (II-III linker, 3' pMT2 polylinker) fragments of EEEE.

CECC-- Domains III and IV of CEEE were replaced via excision of the SalI (II-III linker, 3' pMT2 polylinker) fragment from CCCC.

ECEC-- ECEC was created by replacement of the domain III and IV fragment from ECCC (via SalI digest) with the corresponding fragment from EEEC.

CECE-- CECE was created by replacement of the domain III and IV fragment from CEEE (via SalI digest) with the corresponding fragment from CCCE.

Transient Transfection

Human embryonic kidney (HEK) tSA-201 cells were grown in standard Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 0.5 mg/ml penicillin streptomycin, and 0.4 mg/ml neomycin. The cells were grown to 85% confluency, split with trypsin-EDTA, and plated on glass coverslips at 10% confluency 12 h prior to transfection. Immediately before transfection, the medium was replaced with fresh Dulbecco's modified Eagle's medium, and a standard calcium phosphate protocol was used to transiently transfect the cells with cDNA constructs encoding for calcium channel alpha 1, beta 1b, and alpha 2-delta subunits and green fluorescent protein (7, 7, 7, and 4 µg, respectively). After 12 h, cells were washed with fresh Dulbecco's modified Eagle's medium, and the cells were allowed to recover for 12 h. Subsequently, the cells were incubated at 28 °C in 5% CO2 for 1-3 days prior to recording.

Electrophysiology

Immediately prior to recording, individual coverslips were transferred to a 3-cm culture dish containing external recording solution composed of 20 mM BaCl2, 1 mM MgCl2, 10 mM HEPES, 40 mM TEACl, 10 mM glucose, and 65 mM CsCl (pH 7.2). Whole cell patch clamp recordings were performed using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) linked to a personal computer equipped with pCLAMP version 6.0. Patch pipettes (Sutter borosilicate glass, BF150-86-15) were pulled using a Sutter P-87 microelectrode puller and fire-polished using a Narashige microforge, and they showed a typical resistance of about 3-4 megaohms. The series resistance was typically around 8 megaohms. Because most currents were smaller than 1 nA at the peak of the current voltage relation, voltage errors were calculated to be less than 10 mV in the worst case. For steady state inactivation curves, this has little effect on the half-inactivation potential for two reasons. First, the conditioning potential is not affected by voltage errors, because with the exception of one chimera (ECEE) there was little current activation during the conditioning pulses. Second, the test potential used during the recording of steady state inactivation curves (+20 mV) was typically 10-30 mV more positive than the peak of the I-V relation, resulting in smaller currents and, thus, smaller voltage errors. Any remaining errors may cause a slight skewing of the shape of the steady state inactivation curve at the initial falling phase but very little effect on the measured half-inactivation potential. Consistent with this notion, for any given channel construct we found no correlation between half-inactivation potential and current size. The internal pipette solution contained 105 mM CsCl, 25 mM tetraethylammonium chloride, 11 mM EGTA, and 10 mM HEPES (pH 7.2). Recordings were made from cells expressing the green fluorescent protein gene as visualized by a fluorescence signal. The bath was connected to ground via a 3 M CsCl AGAR bridge. Seals were formed directly in the external control solution. After gigaseal formation, cells were allowed to dialyze for 5-10 min before recordings were performed. Unless stated otherwise, currents were typically elicited from a holding potential of -100 mV to various test potentials using Clampex software (Axon Instruments). We observed only negligible leak currents. At potentials more positive than the reversal potential, outward currents carried presumably by cesium ions could be observed; however, these did not significantly affect our determination of the reversal potential, because data points close to reversal were not considered for fitting of macroscopic current-voltage relations.

Data were filtered at 1 kHz and recorded directly onto personal computer. Data were analyzed using Clampfit (Axon Instruments). All curve fitting was carried out in Sigmaplot 4.0 (Jandel Scientific). Steady state inactivation curves were fitted to the Boltzman equation, Ipeak (normalized) = C + (1 - C)/(1 + exp((V - Vh) z/25.6)), where V and Vh are the conditioning and the half-inactivation potential, respectively, z is a slope factor, and C is the noninactivating fraction. Current-voltage relations were fitted according to the equation Ipeak = (V - Erev)G(1/(1 + exp(Va - V)/S)) where Erev is the reversal potential, Va is the half-activation potential, G is the maximum slope conductance, and S is a slope factor that is inversely proportional to the effective gating charge. Unless stated otherwise, all error bars are S.E., numbers in parentheses displayed in the figures reflect numbers of experiments, and p values given reflect Student's t tests.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Wild type alpha 1C and alpha 1E Calcium Channels Exhibit Distinct Voltage-dependent Inactivation Properties-- It is well established that neuronal (L-type) alpha 1C calcium channels undergo little voltage-dependent inactivation in response to membrane depolarization. In contrast, alpha 1E channels are among the most rapidly inactivating high voltage-activated calcium channel isoforms. Fig. 1 illustrates these intrinsic differences between alpha 1C and alpha 1E (both coexpressed in HEK cells with ancillary alpha 2-delta and beta 1b subunits). As seen in Fig. 1A, alpha 1E channels inactivate much more rapidly than the alpha 1C isoform, and this difference is maintained over a large range of test potentials (Fig. 1C). Generally, we observed some variability in the number of time constants required for fitting the time course of inactivation of alpha 1E (i.e. while in the majority of the cases, a single exponential yielded a satisfactory fit, in some cases two exponentials were required). Hence, in order to facilitate comparison among the different channels, the rate of inactivation is reflected, in Fig. 1C and throughout, as the percentage of peak current that has inactivated over a time course of 150 ms. Note that, because barium was used as the external charge carrier and due to effective buffering of intracellular calcium with EGTA, voltage-dependent inactivation processes are not contaminated by the calcium-sensitive inactivation process intrinsic to L-type calcium channels (39).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Comparison of kinetic properties of wild type rbC-II and rbE-II channels. Inset, proposed transmembrane topology of voltage-dependent calcium channels. Transmembrane domains of the parent alpha 1C channel are depicted in black. The four-letter code (CCCC, EEEE) refers to the origin of the four individual transmembrane domains. A, representative whole cell current traces (IBa) of rbC-II (upper panel) and rbE-II (lower panel) in 20 mM Ba2+. Currents were elicited by a 250-ms step depolarization to +10 mV from a holding potential of -100 mV. The traces were leak-subtracted on line using a p/5 protocol. Note that alpha 1E inactivates much more rapidly than alpha 1C. B, representative current-voltage relations of rbC-II (upper panel) and rbE-II (lower panel) in 20 mM Ba2+ from a holding potential of -100 mV. The I-V plots were fitted as outlined under "Experimental Procedures." The half-activation potential of alpha 1E was typically about 10 mV more negative than that of alpha 1C. C, voltage dependence of the inactivation rates (as determined by the fraction of current inactivated during the course of a 150-ms test depolarization) for rbC-II (circles, n = 9) and rbE-II (triangles, n = 11). D, comparison of steady state inactivation properties of rbC-II (circles, n = 9) and rbE-II (triangles, n = 14). Peak current amplitude was measured immediately subsequent to a 5-s conditioning potential. The data were fitted using the Boltzman equation. The half-inactivation potentials obtained from the fits were -16 mV (z = 3.0) and -58 mV (z = 3.1), respectively, for rbC-II and rbE-II. Error bars reflect S.E.

In addition to their rates of inactivation, the wild type channels also exhibited pronounced differences in their half-inactivation potentials, with alpha 1E inactivating at potentials about 40 mV more negative than alpha 1C (Fig. 1D). In contrast, at least with 20 mM barium as the charge carrier, the half-activation potentials (estimated from Boltzman fits to current voltage relations) of the two wild type channels differed by only about 10 mV (Fig. 1B; see also Table I). Overall, the differences between the inactivation properties of the two wild type channels are sufficiently large to permit a chimerical approach toward the molecular identification of the underlying structural determinants.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Activation and inactivation properties of wild type and chimeric calcium channels
Values were obtained via Boltzman fits of steady state inactivation curves (Fig. 2) and macroscopic current-voltage relations. Note that there is no correlation between half-activation and half-inactivation potentials. Current-density measurements obtained at the peak of the current voltage relation reveal variable levels of expression among the chimeras.

All Four Transmembrane Domains Contribute to Steady State Inactivation-- To investigate the molecular mechanism underlying these differences in voltage-dependent inactivation properties, we constructed a series of 14 chimeras between wild type alpha 1C and alpha 1E calcium channels. Each chimeric construct is formed via combination of the four major transmembrane domains of the two parent channels (see Fig. 2). As described in more detail under "Experimental Procedures," the chimeras were designed such that switches occurred immediately after the end of the S6 segments in domains I and II and about 20 amino acids past that of domain III, and thus each domain remains associated with the preceding cytoplasmic linker region. Of the 14 chimeras, nine constructs were found to form functional calcium channels when expressed in HEK cells.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Nomenclature and steady state inactivation properties of C-E chimeras. Transmembrane topology is shown of the chimeric calcium channel constructs, indicating the nomenclature used throughout. The chimeras were coexpressed with alpha 2-delta and beta 1b subunits. Mean steady state inactivation curves and representative current traces are shown for each chimera. The experimental conditions were as outlined in Fig. 1. Error bars represent S.E. The data were fitted with the Boltzman equation.

Fig. 2 depicts representative current traces and ensemble steady state inactivation curves for each of the nine functional chimeras. In each case, the voltage dependence of steady state inactivation could be nicely described with a Boltzman relation. Several of the chimeras, as well as the wild type alpha 1C channels did not inactivate completely during the 5-s conditioning pulse, and hence the Boltzman fit was modified to incorporate this noninactivating fraction (see "Experimental Procedures"). The half-inactivation potentials and slope factors obtained from these fits (see also Table I) and the shapes of the current waveforms (Fig. 2) were consistent with what one might have expected from our observations with the two wild type channels. Chimera ECCC exhibited somewhat shallow voltage dependences of both inactivation and activation (Table I, Fig. 2).

Fig. 3A compares the half-inactivation potentials of the nine chimeras to the wild type channels in form of a bar graph. Upon examination of Fig. 3A, two observations can be made. First, no single domain switch appears to be able to confer the entire steady state inactivation properties from one parent channel to another. Instead, a continuous spectrum of half-inactivation potentials spanning the range between the two wild type channels was evident. Second, two of the chimeras (CEEC, CCCE) exhibited half-inactivation potentials outside of that range, indicating that some of the individual domains of a particular parent channel may perhaps exert opposing effects on the position of the steady-state inactivation curve along the voltage axis.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Contribution of individual transmembrane domains to steady state inactivation. A, comparison of half-inactivation potentials for wild type and chimerical calcium channels. In each case, steady state inactivation curves from individual experiments were fitted separately, and the means and S.E. are plotted. Numbers in parentheses reflect numbers of experiments. B, replacement of the alpha 1C sequence in domain I with that of alpha 1E mediates a moderate (10-15-mV) hyperpolarizing shift in half-inactivation potential in three out of four pairs of constructs. C and D, replacement of the alpha 1C sequences in either domain II or domain III with those of alpha 1E mediates a strong (20-25-mV) hyperpolarizing shift in half-inactivation for all chimeras tested. E, replacement of the alpha 1C sequence in domain IV with that of alpha 1E produces a depolarizing shift in half-inactivation potential. In each case, an asterisk denotes transitions for which there is a significant shift in Vh (p < 0.05). The numbers in parentheses reflect the ratios of the changes in half-activation potential to the change in half-inactivation potential for each pair of chimeras.

From the graph in Fig. 3A, it is difficult to assess the effects of individual transmembrane domain switches on half-inactivation potential. Hence, in order to isolate the individual contributions of each of the four transmembrane domains to the overall voltage dependence of inactivation, the data of Fig. 3A were divided into individual pairs of chimeras in which only a single domain was exchanged. Fig. 3B examines the effect of replacement of the alpha 1C sequence in domain I with the corresponding sequence from alpha 1E. As evident from the figure, three out of the four chimera pairs examined exhibited a 10-15-mV negative shift in half-inactivation potential when domain I contained the alpha 1E sequence. Upon replacement of the alpha 1C sequence in either domain II or III with that of alpha 1E, a large hyperpolarizing shift of ~20 mV was observed in every case. Thus, structures residing within each of the first three domains contribute to the more negative half-inactivation potential seen with wild type alpha 1E channels. Surprisingly, when the same type of analysis was carried out for substitutions in domain IV, the opposite effect was observed, with alpha 1E domain IV mediating a depolarizing shift in half-inactivation potential when replacing alpha 1C sequence. These data indicate that all four transmembrane domains contribute to steady state inactivation properties of voltage-dependent calcium channels, and furthermore, that the absolute value of the half-inactivation potential of alpha 1E channels is determined through an equilibrium formed by hyperpolarizing and depolarizing structural elements.

Half-inactivation Potential Shifts Are Not Correlated with Activation Effects-- It is known for sodium and potassium channels that inactivation can be tightly coupled to activation. Thus, the above conclusions are somewhat complicated by the notion that not all of the chimeras exhibited identical half-activation potentials (see Table I). The wild type channel differed by less than 10 mV in their half-activation potentials, and yet they exhibited a greater than 40 mV difference in their half-inactivation potentials. Furthermore, when examining the data presented in Table I, one can identify two clusters of constructs with half-activation potentials of about -21 mV (EEEE, EECC, CCEC, CCEE, ECEE) and about -12 mV (CCCC, CEEC, CECC, ECCC), respectively, and yet, within each of these clusters, the half-inactivation potentials varied by as much as 35 and 50 mV, respectively. Overall, these considerations suggest that the distinct activation potentials of the channels are not correlated with the observed differences in inactivation properties. Nonetheless, it is possible that in some cases the activation effects might skew the absolute inactivation potential changes induced by domain swapping. To assess the extent of any putative contamination by activation effects, we calculated the ratio of the change in half-activation potential to the change in half-inactivation potential for each pair of chimeras (see numbers in parentheses, Fig. 3B). A value of 1 indicates that the change in half-inactivation potential parallels the changes in half-activation potential in magnitude, a value near 0 indicates that there is only little if any contamination by activation effects, and a negative value reflects a scenario in which a domain switch resulted in opposite shifts in half-activation and half-inactivation potentials. As seen from Fig. 3, in only two out of 15 cases did the index approach 1, and only four additional chimera pairs displayed ratios greater than 0.1. It is also noteworthy that chimera CEEC differed from the wild type alpha 1C channels by only 4 mV in half-activation potential, while exhibiting a half-inactivation potential that was 55 mV more negative, thus further supporting the notion that domains II and III carry the bulk of the voltage dependence of inactivation. Overall, these considerations suggest that for the majority of chimera pairs, differences in voltage-dependent activation properties could not account for the observed changes in half-inactivation potentials.

We did not systematically examine the effects of individual domains on half-activation potential, because the difference between the two wild type channels was relatively small (<10 mV), and perhaps with the exception of alpha 1E domain III, which tended to shift the half-activation potential into the negative direction (see Table I), none of the individual transmembrane domains appeared to have a clear cut effect on activation range. We suspect that even with more accurate tail current protocols (rather than relying on fits to macroscopic current-voltage relations), we would be unable to attribute the distinct activation ranges of the two wild type channels to individual transmembrane domains.

Transmembrane Domains II, III, and IV Determine Inactivation Rates-- To determine the effects of domain swapping on the rate of inactivation, we compared inactivation of wild type and chimeric calcium channels by using the ratio of peak current to the current observed at the end of a 150-ms test depolarization as a single measure of all voltage-dependent inactivation processes. Fig. 4 depicts the percentage of inactivation that occurred over 150 ms for three different test pulses (0, +10, and +20 mV). Similar to what was observed with the half-inactivation potentials, the inactivation rates of the individual chimeras formed a continuum within the range spanned by the two wild type channels. Overall, this indicates that the rate of inactivation may also be determined by multiple structural domains.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   Inactivation rates for wild type and chimeric calcium channels. Inactivation rates of wild type and chimeric calcium channels, reflected as the percentage of peak current that has inactivated during a 150-ms test pulse, are shown for three different test potentials (0, 10, and 20 mV). Error bars denote S.E.; numbers in parentheses denote the numbers of experiments. Inactivation rates observed with the chimeras are widely distributed between those seen with the wild type channels.

Fig. 5 examines the role of each individual transmembrane domain in determining the rate of inactivation. As seen from Fig. 5A, in only one out of four cases did exchanges of domain I exert a significant effect, suggesting that domain I does not contribute in a substantial manner to the differences in inactivation rate between rat brain alpha 1C and alpha 1E channels. In contrast, in seven out of eight cases, replacing alpha 1C sequences in domains II or III with those corresponding to alpha 1E mediated increases in inactivation rate by 2.5- and 4-fold, respectively. Consistent with what we had observed with steady state inactivation, domain IV of alpha 1E actually slowed the rate of inactivation (by 2.5-fold). This behavior is further illustrated in Fig. 5 with the current records and voltage dependences of the inactivation rates of selected chimera pairs. Insertion of domain I of alpha 1E into the wild type alpha 1C channel had little effect on current waveform or on the magnitude and voltage dependence of the rate of inactivation. Insertion of domain II or III of the wild type alpha 1E channel into alpha 1C mediated a significant speeding of inactivation at all test potentials (Fig. 5, B and C, insets). In fact, there was no significant difference in inactivation rate between chimeras CCEC and the wild type alpha 1E channel at any of the test potentials used indicating that domain III might be perhaps be the most critical determinant of inactivation rate. Finally, in further support of the idea that domain IV of alpha 1E slows inactivation, the CCEE chimera inactivated significantly more slowly than CCEC at all potentials tested.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 5.   Contribution of individual transmembrane domains to inactivation rate. A, exchanging domain I has little effect on inactivation rate. B and C, replacement of alpha 1C sequence in domain II or III with the corresponding alpha 1E sequence mediates a substantial increase in the rate of inactivation. D, replacement of alpha 1C sequence in domain IV with that of alpha 1E slows the rate of inactivation. Inactivation rates for each construct in Fig. 5 were measured at +20 mV and were taken from Fig. 4. The asterisks denote statistically significant changes in inactivation rates (p < 0.05). Insets, representative whole cell current records illustrating the effects of single domain switches on inactivation rates (step depolarizations to +10 mV). Current traces are scaled to the same peak amplitude to allow for comparison of inactivation rates. The voltage dependences of the inactivation rates for a number of experiments are depicted below the current records.

Overall, our data implicate multiple transmembrane domains in the overall voltage-dependent inactivation process of neuronal alpha 1E calcium channels, with domains II and III accounting for the bulk of the effect.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ca2+ Channel Inactivation Is Fundamentally Different from That of Na+ and K+ Channels-- The molecular mechanisms of fast voltage-dependent inactivation of voltage-dependent sodium and potassium channels are well understood. In Shaker K channels, fast inactivation occurs via physical occlusion of the pore by a cluster of about 20 amino acid residues at the amino terminus of the alpha 1 subunit (22, 40). Due to the tetrameric structure of these channels, the presence of four identical inactivation particles has been proposed (41). In voltage-dependent sodium channels, fast inactivation appears to be caused by occlusion of the pore by three hydrophobic residues (Ile, Phe, and Met) located in the domain III-IV linker region of the sodium channel alpha 1 subunit (26). Voltage-dependent calcium channels do not contain analogous structural elements, and no evidence for a pore blocking mechanism has been presented. Zhang et al. (29) have provided compelling evidence that the differences between the inactivation rates of marine ray alpha 1E and rabbit brain alpha 1A channels can be exclusively located to the domain I S6 region. However, more recently, individual point mutations in the domain I-II linker region (7, 11, 31, 35) and the S6 regions of domains III and IV (32-34) have been shown to attenuate or abolish voltage-dependent inactivation of alpha 1A calcium channels, perhaps suggesting the possibility that inactivation of neuronal calcium channels might involve a more diffusely located effect.

Here, we have systematically investigated the roles of each of the four transmembrane domains in voltage-dependent inactivation of alpha 1E channels. Our chimeric approach was designed to be constructive; i.e. our goal was to confer the inactivation properties from a rapidly inactivating channel onto a relatively noninactivating one rather than simple destruction of inactivation. However, while we could confer certain aspects of voltage-dependent inactivation of alpha 1E onto alpha 1C channels through insertion of individual domains, we were unable to attribute the mechanism underlying voltage-dependent inactivation to a single transmembrane domain. Instead, our data indicate that all four transmembrane domains contribute to varying degrees to fast inactivation. The overall half-inactivation potential appears to be determined through an equilibrium between hyperpolarizing (alpha 1E domains I, II, and III) and depolarizing (alpha 1E domain IV) elements. Similarly, the differences in inactivation rate between the two wild type channels appeared to involve predominantly domains II and III, with some contribution from domain IV. Thus, consistent with previous suggestions, the molecular mechanisms that mediate fast inactivation of voltage-dependent calcium channels appear to differ fundamentally from those observed with other type of voltage-gated cation channels.

Putative Effects of Differential Activation Properties-- In principle, it is possible that some of the differences in half-inactivation potentials observed with the chimeric calcium channels might be secondarily due to intrinsic differences in their activation properties. In 20 mM barium, we observed an approximate 10-mV difference in the half-activation potentials of wild type alpha 1E and alpha 1C channels. In contrast, their difference in half-inactivation potential is more than 4-fold larger. Furthermore, with the exception of two out of 15 chimera pairs, we found no correlation between shifts in half-activation and half-inactivation potentials resulting from the switching of individual or multiple domains, suggesting that changes in half-activation potential cannot account for our observations and that the effects observed with our chimeras are indeed due to structural changes in the voltage-dependent inactivation machinery.

The effects of individual domain exchanges on the inactivation rate were examined at the same test potential (+20 mV). Because the rate of inactivation may be coupled to channel activation, any variability in half-activation potential among the chimeras/wild type channels might affect the comparison of inactivation rates measured at a single arbitrary test potential. However, this variability in half-activation potential was fairly small (nine of the 11 chimeras activated within a 10-mV window), and thus, given the shallow voltage dependences of the inactivation rates, our interpretations are not likely to be affected.

Comparison with Previous Work-- At first glance, our data appear to contradict those of Zhang et al. (29). However, two issues must be taken into consideration. First, wild type alpha 1E and alpha 1C channels exhibit much more pronounced differences in inactivation rate and in half-inactivation potential compared with the channels used by Zhang et al. (29) to create their chimeras (i.e. alpha 1E and alpha 1A, which are phyllogenetically quite closely related). Thus, it is possible that both parent channels may carry similar "inactivation" motifs in domains II, III, and IV but differ predominantly in domain I. In our case, due to the lower degree of overall homology shared by alpha 1E and alpha 1C channels, the regions critical for inactivation might perhaps be more divergent, thus revealing the contributions of additional domains to the overall inactivation process. A second fundamental difference between the present study and that of Zhang et al. lies in the type of transient expression system used, with Zhang et al. (29) using Xenopus oocytes as compared with the HEK cells in our experiments. It is well established that the type of host system frequently affects the functional and pharmacological properties of transiently expressed ion channels (e.g. Ref. 42), and it will be interesting to examine the properties of our chimeras in Xenopus oocytes. Finally, our data do support some contribution of domain I in the overall inactivation properties, since substitution of alpha 1C sequence in domain I with that corresponding to alpha 1E mediated a 10-15-mV negative shift in half-inactivation potential.

Two groups have pinpointed individual amino acid residues in the domain I-II linker as critical determinants of voltage-dependent inactivation. An alternative splice variant of the rat brain alpha 1A channel that carries a single valine insertion in the domain I-II linker completely lacks voltage-dependent inactivation (7, 11, 31). Herlitze et al. (35) identified a single amino acid residue in the domain I-II linker of alpha 1A that can confer positive inactivation properties onto L-type calcium channels. In the present study, the domain I-II linker was always associated with domain II. Thus, although Zhang et al. (29) showed that exchanging the I-II linker region between doe-I and alpha 1A channels did not affect inactivation rate, we cannot rule out that the effects that we attribute to "domain II" may be contained, in part, in the domain I-II linker rather than the actual domain II region per se. The same consideration applies in principle to domain III and the carboxyl-terminal region. Ultimately, swapping of individual cytoplasmic linker regions will be required to elucidate any putative contributions of the cytoplasmic linkers to voltage-dependent inactivation properties.

What Might Be the Molecular Mechanism of Fast Ca2+ Channel Inactivation?-- Our observation that each of the four transmembrane domains appeared to affect voltage-dependent inactivation might suggest that calcium channel inactivation involves a complex global conformational change in the channel protein. Most of the structures or amino acid residues that have been linked to changes in voltage-dependent inactivation of various types of calcium channels have been located to the S6 regions in domains I, III, and IV (29, 32-34, 43), or to cytoplasmic regions directly linked to these S6 segments such as the domain I-II linker or the carboxyl-terminal region (36, 44). In addition, cytoplasmic proteins such as ancillary beta  subunits and syntaxin that physically bind to the domain I-II linker (45) and II-III linker regions, respectively, have been shown to affect voltage-dependent inactivation properties. In view of our current understanding of the slower C-type inactivation process in certain types of voltage-dependent potassium channels (46-51), we hypothesize that voltage-dependent inactivation of calcium channels could perhaps involve a physical constriction of the pore. Similar to what has been proposed to occur during C-type inactivation of potassium channels, the cytoplasmic ends of the S6 segments might come together to form an inverted teepee structure during inactivation, thereby preventing the passage of permeant ions through the pore. Such a mechanism could account for the previously reported mutagenesis data in both the S6 regions and the associated linker regions as well as for the effects of protein interactions with the linker regions. For example, the structural changes in the linker regions might affect the mobility or flexibility of the associated S6 regions and thus the overall inactivation properties. Furthermore, in such a model, one would expect to observe some contribution from each transmembrane domain as reported here. Hence, while we cannot rule out the possibility that the four transmembrane domains might cooperatively form a docking site for a yet to be identified inactivation gate particle, a mechanism similar to that proposed to underlie C-type inactivation of potassium channels is an attractive possibility. Construction of additional chimeras and/or site-directed mutagenesis will be required, however, to further support such a hypothesis. Overall, irrespective of the detailed molecular mechanisms involved, our data are consistent with the notion that voltage-dependent inactivation of alpha 1E calcium channels is complex process that involves multiple structural domains and thus differs fundamentally from fast inactivation of sodium and potassium channels.

    ACKNOWLEDGEMENTS

We thank Dr. Terry Snutch for providing wild type calcium channel cDNAs and Dr. William Catterall for comments on the data.

    FOOTNOTES

* This work was supported in part by operating grants from the Heart and Stroke Foundation of Alberta & Northwest Territories and from the Medical Research Council of Canada (MRC) and by an equipment award from the Canada Foundation for Innovation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of an Alberta Heritage Foundation for Medical Research (AHFMR) studentship.

§ Recipient of faculty Scholarships from the MRC, the AHFMR, and the EJLB Foundation. To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. Tel.: 403-220-8687; Fax: 403-283-8731; E-mail: Zamponi@acs.ucalgary.ca.

    ABBREVIATIONS

The abbreviation used is: bp, base pair(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Williams, M. E., Feldman, D. H., McCue, A. F., Brenner, R., Velicelebi, G., Ellis, S. B., and Harpold, M. M. (1992) Neuron 8, 71-84[CrossRef][Medline] [Order article via Infotrieve]
2. Tomlinson, W. J., Stea, A., Bourinet, E., Charnet, P., Nargeot, J., and Snutch, T. P. (1993) Neuropharmacology 32, 1117-1126[CrossRef][Medline] [Order article via Infotrieve]
3. Bech-Hansen, N. T., Naylor, M. J., Maybaum, T. A., Pearce, W. G., Koop, B., Fishman, G. A., Mets, M., Musarella, M. A., and Boycott, K. M. (1998) Nat. Genet. 19, 264-267[CrossRef][Medline] [Order article via Infotrieve]
4. Dubel, S. J., Starr, T. V., Hell, J., Ahlijanian, M. K., Enyeart, J. J., Catterall, W. A., and Snutch, T. P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5058-5062[Abstract/Free Full Text]
5. Williams, M. E., Brust, P. F., Feldman, D. H., Patthi, S., Simerson, S., Maroufi, A., McCue, A. F., Velicelebi, G., Ellis, S. B., and Harpold, M. M. (1992) Science 257, 389-395[Abstract/Free Full Text]
6. Fujita, Y., Mynlieff, M., Dirksen, R. T., Kim, M. S., Niidome, T., Nakai, J., Friedrich, T., Iwabe, N., Miyata, T., Furuichi, T., Furutama, D., Mikoshiba, K., Mori, Y., and Beam, K. G. (1993) Neuron 10, 585-598[CrossRef][Medline] [Order article via Infotrieve]
7. Bourinet, E., Soong, T. W., Zamponi, G. W., Stea, A., Nargeot, J., and Snutch, T. P. (1996) Soc. Neurosci. Abstr. 22, 343
8. Mori, Y., Friedrich, T., Kim, M. S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., Mikoshiba, K., Imoto, K., Tanabe, T., and Numa, S. (1991) Nature 350, 398-402[CrossRef][Medline] [Order article via Infotrieve]
9. Sather, W. A., Tanabe, T., Zhang, J. F., Mori, Y., Adams, M. E., and Tsien, R. W. (1993) Neuron 11, 291-303[CrossRef][Medline] [Order article via Infotrieve]
10. Stea, A., Tomlinson, W. J., Soong, T. W., Bourinet, E., Dubel, S. J., Vincent, S. R., and Snutch, T. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10576-10580[Abstract/Free Full Text]
11. Sutton, K. G., Zamponi, G. W., Bourinet, E., Soong, T. W., and Snutch, T. P. (1998) Soc. Neurosci. Abstr. 24, 21
12. Cribbs, L. L., Lee, J. H., Yang, J., Satin, J., Zhang, Y., Daud, A., Barclay, J., Williamson, M. P., Fox, M., Rees, M., and Perez-Reyes, E. (1998) Circ. Res. 83, 103-109[Abstract/Free Full Text]
13. Perez-Reyes, E., Cribbs, L. L., Daud, A., Lacerda, A. E., Barclay, J., Williamson, M. P., Fox, M., Rees, M., and Lee, J. H. (1998) Nature 391, 896-900[CrossRef][Medline] [Order article via Infotrieve]
14. Soong, T. W., Stea, A., Hodson, C. D., Dubel, S. J., Vincent, S. R., and Snutch, T. P. (1993) Science 260, 1133-1136[Abstract/Free Full Text]
15. Williams, M. E., Marubio, L. M., Deal, C. R., Hans, M., Brust, P. F., Philipson, L. H., Miller, R. J., Johnson, E. C., Harpold, M. M., and Ellis, S. B. (1994) J. Biol. Chem. 269, 22347-22357[Abstract/Free Full Text]
16. Tottene, A., Moretti, A., and Pietrobon, D. (1997) J. Neurosci. 16, 6353-6363[Abstract/Free Full Text]
17. Choi, D. W. (1988) Trends Neurosci. 11, 465-469[CrossRef][Medline] [Order article via Infotrieve]
18. Orrenius, S., McConkey, D. J., Bellomo, G., and Nicotera, P. (1989) Trends Pharmacol. Sci. 10, 281-285[CrossRef][Medline] [Order article via Infotrieve]
19. Orrenius, S., and Nicotera, P. (1994) J. Neural Transm. Suppl. 43, 1-11[Medline] [Order article via Infotrieve]
20. Forsythe, I. D., Tsujimoto, T., Barnes-Davies, M., Cuttle, M. F., and Takahashi, T. (1998) Neuron 20, 797-807[CrossRef][Medline] [Order article via Infotrieve]
21. Patil, P. G., Brody, D. L., and Yue, D. T. (1998) Neuron 20, 1027-1038[CrossRef][Medline] [Order article via Infotrieve]
22. Zagotta, W. N., Hoshi, T., and Aldrich, R. W. (1990) Science 250, 506-507[Free Full Text]
23. Hoshi, T., Zagotta, W. N., and Aldrich, R. W. (1991) Neuron 7, 556-574
24. Isacoff, E. Y., Jan, Y. N., and Jan, L. Y. (1991) Nature 353, 86-90[CrossRef][Medline] [Order article via Infotrieve]
25. Vassilev, P., Scheuer, T., and Catterall, W. A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 8147-8151[Abstract/Free Full Text]
26. Eaholtz, G., Scheuer, T., and Catterall, W. A. (1994) Neuron 12, 1041-1048[CrossRef][Medline] [Order article via Infotrieve]
27. Armstrong, C. M., and Bezanilla, F. (1977) J. Gen. Physiol. 70, 567-590[Abstract/Free Full Text]
28. Stuhmer, W., Conti, F., Suzuki, H., Wang, X. D., Yahagi, N., Kubo, H., and Numa, S. (1989) Nature 339, 597-603[CrossRef][Medline] [Order article via Infotrieve]
29. Zhang, J. F., Ellinor, P. T., Aldrich, R. W., and Tsien, R. W. (1994) Nature 372, 97-100[CrossRef][Medline] [Order article via Infotrieve]
30. Bernatchez, G., Talwar, D., and Parent, L. (1998) Biophys. J. 75, 1727-1739[Abstract/Free Full Text]
31. Zamponi, G. W., Soong, T. W., Bourinet, E., and Snutch, T. P. (1996) J. Neurosci. 16, 2430-2443[Abstract/Free Full Text]
32. Hering, S., Aczel, S., Grabner, M., Doring, F., Berjukow, S., Mitterdorfer, J., Sinnegger, M. J., Striessnig, J., Degtiar, V. E., Wang, Z., and Glossmann, H. (1996) J. Biol. Chem. 271, 24471-24475[Abstract/Free Full Text]
33. Hering, S., Aczel, S., Kraus, R. L., Berjukow, S., Striessnig, J., and Timin, E. N. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13323-13328[Abstract/Free Full Text]
34. Hering, S., Berjukow, S., Aczel, S., and Timin, E. N. (1998) Trends Pharmacol. Sci. 19, 439-443[CrossRef][Medline] [Order article via Infotrieve]
35. Herlitze, S., Hockerman, G. H., Scheuer, T., and Catterall, W. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1512-1516[Abstract/Free Full Text]
36. Soldatov, N. M., Zuhlke, R. D., Bouron, A., and Reuter, H. (1997) J. Biol. Chem. 272, 3560-3566[Abstract/Free Full Text]
37. Choi, K. L., Aldrich, R. W., and Yellen, G. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5092-5095[Abstract/Free Full Text]
38. Kukuljan, M., Lebarca, P., and Latorre, R. (1995) Am. J. Physiol. 268, C535-C556[Abstract/Free Full Text]
39. Imredy, J. P., and Yue, D. T. (1994) Neuron 12, 1301-1318[CrossRef][Medline] [Order article via Infotrieve]
40. Demo, S. D., and Yellen, G. (1991) Neuron 7, 743-753[CrossRef][Medline] [Order article via Infotrieve]
41. MacKinnon, R., Aldrich, R. W., and Lee, A. W. (1993) Science 262, 757-759[Abstract/Free Full Text]
42. Zamponi, G. W. (1999) J. Membr. Biol. 167, 183-192[CrossRef][Medline] [Order article via Infotrieve]
43. Hockerman, G. H., Johnson, B. D., Abbott, M. R., Scheuer, T., and Catterall, W. A. (1997) J. Biol. Chem. 272, 18759-18765[Abstract/Free Full Text]
44. Schmid, R., Seydl, K., Baumgartner, W., Groschner, K., and Romanin, C. (1995) Biophys. J. 69, 1847-1857[Abstract/Free Full Text]
45. Pragnell, M., DeWaard, M., Mori, Y., Tanabe, T., Snutch, T. P., and Campbell, K. P. (1994) Nature 368, 67-70[CrossRef][Medline] [Order article via Infotrieve]
46. Durrell, S. R., Hao, Y., and Guy, H. R. (1998) J. Struct. Biol. 73, 157-167
47. Holmgren, M., Shin, K. S., and Yellen, G. (1998) Neuron 21, 617-621[CrossRef][Medline] [Order article via Infotrieve]
48. Liu, Y., Jurman, E., and Yellen, G. (1996) Neuron 16, 859-867[CrossRef][Medline] [Order article via Infotrieve]
49. Ogielska, E. M., Zagotta, W. N., Hoshi, T., Heinemann, S. H., Haab, J., and Aldrich, R. W. (1995) Biophys. J. 69, 2449-2457[Abstract/Free Full Text]
50. Panyi, G., Sheng, Z., Tu, L., and Deutsch, C. (1995) Biophys. J. 69, 896-903[Abstract/Free Full Text]
51. Yellen, G., Sodickson, D., Chen, T. Y., and Jurman, M. E. (1994) Biophys. J. 66, 1068-1075[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike